MSC to Aid Vietnam's Development into Regional Cargo Transshipment Hub
Leading container shipping company MSC has expressed interest in expanding its investments in Vietnam's port and logistics sectors, citing the country's economic growth and development strategy. The company is particularly keen on the Can Gio International Transshipment Port project, aiming to develop Vietnam into a regional cargo transshipment hub.
Read up to 3 eligible full articles per Japan day (JST) for free
Create a free account to open up to 3 eligible full articles per Japan calendar day (JST). Headlines and summaries remain available across ASEAN 7.
Related articles
- Vietnam Approves Pharmaceutical Industry Development Program Through 2030
The Vietnamese government has approved a development program for its chemical and pharmaceutical industry through 2030. The plan aims to establish R&D centers meeting international standards, improve quality compliance for domestic manufacturers, and promote digitalization. This initiative seeks to enhance self-sufficiency in pharmaceutical raw materials and strengthen participation in global supply chains.
- Angkormilk Project: A Testament to Vietnamese Businesses' Success in Cambodia
The Angkormilk project in Cambodia, spearheaded by Vietnamese dairy giant Vinamilk, is emerging as a prime example of Vietnamese businesses' successful international expansion. This initiative underscores the significance of economic, trade, and investment cooperation between Vietnam and Cambodia.
- Hung Yen Selects New Developer for VND15.6 Trillion Urban Area Project
Hung Yen Province, Vietnam, has selected a three-month-old company as the investor for the Me So New Urban Area project, with a total investment of VND15.6 trillion (approximately $610 million). The company recently increased its charter capital, signaling new developments in Vietnam's real estate sector.
- Traphaco Fined VND 160 Million for Drug Manufacturing Violations
Vietnam's leading pharmaceutical firm Traphaco has been fined VND 160 million by the Drug Administration of Vietnam for manufacturing drugs with unapproved changes and using production processes inconsistent with approved records. The company has been urged to strictly adhere to quality control and regulatory compliance.